Herpes Zoster (VZV) Linked to Stroke; CBCD Reviews the Medical Literature
Industry: Health & Fitness
A study found a link between herpes zoster (VZV) and stroke. The CBCD reviews the study and recommends two natural antiviral treatments.
Rochester, NY (PRUnderground) June 11th, 2014
“Are you infected with VZV? We recommend taking Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD
Herpes Zoster (HZ) is linked to stroke. Herpes Zoster, a condition caused by the Varicella Zoster Virus (VZV), increases the risk of transient ischemic attacks (TIA) (a disruption of blood flow), and for stroke (a disruption of blood flow in the brain). (1) Doctors Breuer, Pacou, Gauthier, and Brown M.D. discovered that the VZV virus increases the risk of stroke, transient ischemic attack, and heart attack dramatically. “Risk factors for vascular disease were significantly increased in cases of HZ compared with controls… (and)…TIA and MI were increased in cases whose HZ occurred when they were younger than 40 years.” (1) According to study authors, the main point is that “…conditions that predispose to vascular disease…are significantly more common in subjects with HZ.” (1) Doctors Breuer, Pacou, Gauthier, and Brown M.D. are from the Institute of Neurology at University College London.
The CDC notes that herpes zoster, or “HZ” and commonly known as shingles “is a painful skin rash. It is caused by varicella zoster virus (VZV), the same virus that causes chickenpox. Nearly 1 out of every 3 people in the United States will develop shingles in their lifetime. Anyone who has had chickenpox or received chickenpox vaccine in the past may develop shingles.” (2)
The CBCD recommends that people who have had chickenpox in the past take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (VZV) … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.
The same study found that, “at autopsy, viral inclusions, DNA, and antigen present in cerebral arteries confirms that VZV vasculopathy in these patients is associated with stroke and TIA.” (1) In other words, after death it was discovered that a main cause of stroke in these individuals was the Varicella Zoster Virus.
(1) Breuer J1, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014 Jan 21;82(3):206-12.
(2) CDC – Shingles (Herpes Zoster). http://www.cdc.gov/shingles/index.html?source=govdelivery
(3) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8 http://dx.doi.org/10.4236/pp.2013.46A001
The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.